Abstract
To study the change in trend of ear, nose and throat (ENT) manifestations in patients who were on treatment, before and after availability of highly active antiretroviral therapy (HAART). To find out the prevalence of ENT manifestations in human immunodeficiency virus (HIV) infected people who were on treatment, in the year of 2004 (before the availability of HAART) and in 2014 (after the availability of HAART). Design A combination of a retrospective and prospective study. Setting Anti Retroviral Therapy (ART) Center at Our Hospital. Subjects Patients with HIV infection on ART. Methods Retrospective review of case records of the patients visiting the center in the year 2004 and prospective study of the patients visiting in the year 2014 was conducted. Sample size was calculated as 200 in each group based on 95% confidence and 96% power. Convenience sampling was used in our study. The prevalence of ENT manifestations in HIV patients were found to be 86% in 2004 and 93% in 2014. Among ENT manifestations oropharyngeal manifestations were most common. Lesser the CD4 count more was the prevalence of disorders in oropharynx. Our study showed a high prevalence of ENT manifestations in HIV patients who were on treatment, irrespective of the gap of 10 years and introduction of HAART therapy. Most common ENT manifestation both in 2004 and 2014 was oropharyngeal candidiasis. Lesser the CD4 count more was the prevalence of disorders in oropharynx.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
UNAIDS/WHO. UNAIDS report on the global AIDS epidemic 2012. http://www.unaids.org/en/regionscountries/countries/india/
Prasad HK, Bhojwani KM, Shenoy V, Prasad SC (2006) HIV manifestations in otolaryngology. Am J Otolaryngol 27:179–185
Campanini A, Marani M, Mastroianni A, Cancellieri C, Vicini C (2005) HIV infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies. Acta Otorhinolaryngol Ital 25:30–35
Soucek S, Michaels L (1996) The ear in the acquired immunodeficiency syndrome: clinical and audiologic investigation. Am J Otol 17:35–39
Pinheiro RDS, Franca TT, Ribeiro CM, Leao JC, de Souza IP, Castro G (2009) Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era. J Oral Pathol Med 38:613–622
Sulyman AB, Kazeem SA, Abdulrahman A, David D, KayodeA S, Oluwayemisi O et al (2010) Otolaryngologic manifestations among HIV/AIDS patients in a nigerian tertiary health institution: an update. Int Arch Otorhinolaryngol 14:398–403
Jafari S, Razmpa E, Saeedinejad Z, Sadrhosseini M, Paydary K, Saedi B et al (2004) Otolaryngological manifestations in HIV infected patients, Tehran, Iran. J AIDS Clin Res 45:56–59
Swai H (2011) Otorhinolaryngological manifestations among HIV infected patients attending HIV clinic at Muhimbili National Hospital. Muhimbili Uni. Of Health and Allied Sciences. http://ihi.eprints.org/927/1/muhas(5).pdf
Funding
Financial support of INR 10,000/– was provided by Indian Council for Medical Research (ICMR-STS 2014, Reference ID—2014-01552).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Dosemane, D., Kumar, V., Madi, D. et al. Human Immunodeficiency Virus Infection: Does Highly Active Antiretroviral Therapy Influence Ear Nose Throat Manifestations?. Indian J Otolaryngol Head Neck Surg 70, 555–558 (2018). https://doi.org/10.1007/s12070-018-1420-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-018-1420-6